Reviewing Reports of Ketoacidosis With SGLT2 Inhibitors
Jennifer N. Clements, PharmD, BPCS, CDE, BCACP, reviews some details of the reports of ketocacidosis with the use of SGLT2 inhibitors.
All articles by Jennifer Clements, PharmD, BCPS, CDE, BCACP
Mortality Risk in Type 1 Diabetes
One study demonstrating increased mortality among patients with type 1 diabetes implicates the importance of glycemic control.
Pramlintide: Where Does It Fit into Diabetes Care?
Reflections on the drug may raise questions about when to use pramlintide in diabetes.
Liraglutide as Saxenda for Obesity
Jennifer N. Clements, PharmD, BCPS, CDE, BCACP, discusses the pros and cons of liraglutide as a new therapy for weight management.
New Year, New Recommendations for Diabetes Care
A new ADA and EASD position statement along with the ADA’s revised Standards of Medical Care in Diabetes have surprising updates.
Considering Qsymia for Obese Patients With Type 2 Diabetes
Evidence shows that the maximum dose of Qsymia is effective for obese patients with type 2 diabetes, but clinicians should still consider all factors.
